Adverse events occurring after smallpox vaccination (Q35197420)

7 August 2017

1 reference

title

Adverse events occurring after smallpox vaccination (English)

1 reference

7 August 2017

1 reference

0 references

J Michael Lane

1 reference

7 August 2017

Joel Goldstein

series ordinal

1 reference

7 August 2017

publication date

1 July 2003

1 reference

Seminars in pediatric infectious diseases

7 August 2017

published in

1 reference

7 August 2017

1 reference

7 August 2017

1 reference

7 August 2017

page(s)

189-195

1 reference

Complications of smallpox vaccination, 1968.

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1045-1870%2803%2900032-3

7 January 2021

Smallpox in Europe, 1950-1971

1 reference

https://api.crossref.org/works/10.1016%2FS1045-1870%2803%2900032-3

7 January 2021

The case for voluntary smallpox vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1045-1870%2803%2900032-3

7 January 2021

Clinical responses to undiluted and diluted smallpox vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1045-1870%2803%2900032-3

7 January 2021

Smallpox research activities: U.S. interagency collaboration, 2001

1 reference

https://api.crossref.org/works/10.1016%2FS1045-1870%2803%2900032-3

7 January 2021

Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1045-1870%2803%2900032-3

7 January 2021

ANTIBODY RESPONSE TO CUTANEOUS INOCULATION WITH VACCINIA VIRUS: VIREMIA AND VIRURIA IN VACCINATED CHILDREN.

1 reference

https://api.crossref.org/works/10.1016%2FS1045-1870%2803%2900032-3

7 January 2021

Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety

1 reference

https://api.crossref.org/works/10.1016%2FS1045-1870%2803%2900032-3

7 January 2021

Bioterrorism. In search of a kinder, gentler vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1045-1870%2803%2900032-3

7 January 2021

Safety of modified vaccinia virus Ankara (MVA) in immune-suppressed macaques.

1 reference

https://api.crossref.org/works/10.1016%2FS1045-1870%2803%2900032-3

7 January 2021

NYVAC: a highly attenuated strain of vaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FS1045-1870%2803%2900032-3

7 January 2021

Public health. Looking for vaccines that pack a wallop without the side effects

1 reference

https://api.crossref.org/works/10.1016%2FS1045-1870%2803%2900032-3

7 January 2021

An antigenic difference between intracellular and extracellular rabbitpox virus

1 reference

https://api.crossref.org/works/10.1016%2FS1045-1870%2803%2900032-3

7 January 2021

An Analysis of Effector T Cell Generation and Function in Mice Exposed to Influenza A or Sendai Viruses

1 reference

https://api.crossref.org/works/10.1016%2FS1045-1870%2803%2900032-3

7 January 2021

Developing new smallpox vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1045-1870%2803%2900032-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS1045-1870%2803%2900032-3

1 reference

7 January 2021

Managing pediatric atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1045-1870%2803%2900032-3

7 January 2021

The prevalence of atopic dermatitis in Oregon schoolchildren

1 reference

https://api.crossref.org/works/10.1016%2FS1045-1870%2803%2900032-3

7 January 2021

Smallpox vaccination: Risk considerations for patients with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1045-1870%2803%2900032-3

7 January 2021

Ocular vaccinia. An epidemiologic analysis of 348 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1045-1870%2803%2900032-3

7 January 2021

Therapy of experimental vaccinal keratitis. Effect of idoxuridine and VIG

1 reference

https://api.crossref.org/works/10.1016%2FS1045-1870%2803%2900032-3

7 January 2021

FATAL MYOCARDITIS AFTER VACCINATION AGAINST SMALLPOX. REPORT OF A CASE

1 reference

https://api.crossref.org/works/10.1016%2FS1045-1870%2803%2900032-3

7 January 2021

Fatal myocarditis following smallpox vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1045-1870%2803%2900032-3

7 January 2021

Contact vaccinia--transmission of vaccinia from smallpox vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1045-1870%2803%2900032-3

7 January 2021

How contagious is vaccinia?

1 reference

https://api.crossref.org/works/10.1016%2FS1045-1870%2803%2900032-3

7 January 2021

Progressive Vaccinia Treated with Ribavirin and Vaccinia Immune Globulin

1 reference

https://api.crossref.org/works/10.1016%2FS1045-1870%2803%2900032-3

7 January 2021

Orally available cidofovir derivative active against smallpox

1 reference

https://api.crossref.org/works/10.1016%2FS1045-1870%2803%2900032-3

7 January 2021

Bioterrorism. Smallpox vaccinations: how much protection remains?

1 reference

https://api.crossref.org/works/10.1016%2FS1045-1870%2803%2900032-3

7 January 2021

The persistence of neutralizing antibodies after revaccination against smallpox

1 reference

https://api.crossref.org/works/10.1016%2FS1045-1870%2803%2900032-3

7 January 2021

US military smallpox vaccination program experience

1 reference

https://api.crossref.org/works/10.1016%2FS1045-1870%2803%2900032-3

7 January 2021

Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel

1 reference

https://api.crossref.org/works/10.1016%2FS1045-1870%2803%2900032-3

7 January 2021

10.1016/S1045-1870(03)00032-3

Identifiers

DOI

1 reference

7 August 2017

1 reference